Active

NOVICREO

Switched

BE0885428866

Rechtspersoon Private limited company 1 establishment

Rue de Hanret, C.-W. 14, 5380 Fernelmont Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Active for

19 year, 9 months

Financials

Financial year 2025

Gross margin

€ 154,907

▼ 63% vs 2024

Profit

Healthy

€ 115,461

▼ 59% vs 2024

Debts

Low

€ 88,861

▼ 11% vs 2024

NOVICREO from Fernelmont, company number BE0885428866, closed financial year 2025 with a result of € 115,461 after tax. For that financial year NOVICREO recorded a gross margin of € 154,907 and equity of € 519,259. Compared with financial year 2024, the result moved from € 284,572 to € 115,461. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What happened at NOVICREO?

What happened at NOVICREO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 115,461 (▼ 59% vs 2024). Source: NBB ↗
  • New establishment in Fernelmont. KBO
  • DOMINIQUE DEMOLLE became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 101,551 profit in 2021 to € 115,461 profit in 2025.

Paid € 213,237 in corporate taxes since 2021.

Best year ever: 2024, with € 284,572 profit.

Paid out € 115,000 in dividends to the owners in total.

A new publication or filing at NOVICREO? We notify you, reason included.

Follow NOVICREO

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

DOMINIQUE DEMOLLE
NOVICREO

Behind NOVICREO is DOMINIQUE DEMOLLE. It owns 2.6% of TOOLS4PATIENT itself.

See the full network in the app

Directors

According to the 2025 annual accounts

DOMINIQUE DEMOLLE

Director

Also active at: Tools4Patient

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Hanret, C.-W. 14

5380 Fernelmont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0885.428.866
VAT number
BE 0885.428.866
Registered office
Rue de Hanret, C.-W. 14, 5380 Fernelmont
Names & denominations
NOVICREO
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
22 November 2006
Peppol
Active · Active since 4 Dec 2025
Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige vormen van onderwijs

Catering van evenementen

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Uitzendkoks en verzorgen van feesten en recepties

Computeradviesbureaus

+2

Frequently asked questions

What is the enterprise number of NOVICREO?
The enterprise number of NOVICREO is BE0885428866.
What is the address of NOVICREO?
The registered office of NOVICREO is located at Rue de Hanret, C.-W. 14, 5380 Fernelmont.
When was NOVICREO founded?
NOVICREO was founded on 22 November 2006.
What is the main activity of NOVICREO?
The main activity of NOVICREO is "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied" (NACE code 72109).
Does NOVICREO have a website?
No website is currently known for NOVICREO.
How much profit did NOVICREO make in 2025?
NOVICREO posted a profit after taxes of € 115,461 in financial year 2025.
What is the revenue of NOVICREO?
As a small company, NOVICREO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 154,907.
Where can I find the annual accounts of NOVICREO?
NOVICREO files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of NOVICREO?
According to the 2025 annual accounts, the directors of NOVICREO are: DOMINIQUE DEMOLLE.
Who owns NOVICREO?
Behind NOVICREO is DOMINIQUE DEMOLLE. It owns 2.6% of TOOLS4PATIENT itself.